Current price is more than the intrinsic value

Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Suven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 13147.01 Crore) operating in Pharmaceuticals sector.

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharma Consolidated March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y

The company had reported a profit after tax (PAT) of Rs 83 crore in the January-March quarter of 2020-21 fiscal.

Suven Pharma Q4 net up 11% at Rs 92 crore | The Financial Express

UPL, PVR, Godrej Agrovet, Infibeam Avenues, Dalmia Bharat, 3i Infotech, Aarti Drugs, BASF India, Borosil, Central Bank of India, CMS Info Systems, Craftsman Automation, Vedant Fashions, Suven Pharmaceuticals are among the key companies scheduled to release their quarterly earnings today

Stocks to Watch: Reliance Industries, HCL Tech, LTI, Mindtree, Tata Power

Suven will purchase100% of share capital from CPPL existing investors. Suven didn’t provide details like annual turnover of the acquired asset citing that CPPL is yet to reach commercially viable operations.

Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore

In the past three months, Suven Pharma has outperformed the market by soaring 30 per cent, as against less than a per cent rise in the Sensex.

Suven Pharma gains 5% to hit record high; stock rallies 18% in three days

Suven Pharma remains conservative in its outlook and provides visibility for the next six months. It is confident of executing Q3 sales run rate for the next two quarters

Suven Pharma: Steady cash flow conversion opportunity merits attention

Endurance Technologies Ltd, Deepak Fertilizers & Petrochemicals Corp Ltd, BASF India Ltd and Suven Pharmaceuticals Ltd are among the other losers in the BSE’s ‘A’ group today, 09 February 2022.

Stove Kraft Ltd leads losers in ‘A’ group

Suven Pharma Consolidated December 2021 Net Sales at Rs 391.59 crore, up 42.43% Y-o-Y

Dr. Srivari first joined as a Scientist in the Council of Scientific and Industrial Research – Indian Institute of Chemical Technology.

Dr Chandrashekhar Srivari resigns from Suven Pharma as Non-executive Independent Director

Suven Pharmaceuticals is engaged in  Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharma Consolidated March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y

Suven Pharma Q4 net up 11% at Rs 92 crore | The Financial Express

Stocks to Watch: Reliance Industries, HCL Tech, LTI, Mindtree, Tata Power

Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore

Suven Pharma gains 5% to hit record high; stock rallies 18% in three days

Suven Pharma: Steady cash flow conversion opportunity merits attention

Stove Kraft Ltd leads losers in ‘A’ group

Suven Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Suven Pharma - CDMO Core Growth Intact; Formulations To Pick Up: Anand Rathi

Buy Suven Pharmaceuticals, target price Rs 627: Anand Rathi

Suven Pharma Consolidated March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y

Suven Pharma Q4 net up 11% at Rs 92 crore | The Financial Express

Stocks to Watch: Reliance Industries, HCL Tech, LTI, Mindtree, Tata Power

Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 crore

Suven Pharma gains 5% to hit record high; stock rallies 18% in three days

Suven Pharma: Steady cash flow conversion opportunity merits attention

Stove Kraft Ltd leads losers in ‘A’ group

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock